Role of Bromocriptine in patients with difficulty in speech following stroke
Phase 2
- Conditions
- Health Condition 1: null- Stroke patients with aphasia
- Registration Number
- CTRI/2013/04/003539
- Lead Sponsor
- Dr Reeba Sini Jacob
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 88
Inclusion Criteria
a)18 years of age and above
b)CT/MRI confirmed diagnosis of Right, Left or bilateral hemispheric thrombotic infarct
c)With premorbid ability to read and write
d)Within 6 months of onset of nonfluent aphasia
Exclusion Criteria
a)Any patient with hearing, visual impairment or both
b)History of malignancy
c)Evidence of severe cardiac, hepatic, renal, pulmonary or other chronic or neuropsychiatric disorder, as determined by history, physical examination, and screening laboratory tests.
d)Those unwilling to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method verbal fluency, comprehension, repetition and naming using the Western Aphasia BatteryTimepoint: 0 and 16 weeks
- Secondary Outcome Measures
Name Time Method Patients are assessed with speech evaluation by noting changes in verbal fluency, comprehension, repetition and naming using the Western Aphasia Battery.Timepoint: 0, 8, 16 and 24 weeks